Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS.

Endocr Connect · 2018 · PMC5754509 · PMID 29295870

Europe PMC DOI

hedged sentences

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

borderline significantP = 0.057so close (0.05 < p ≤ 0.1)

This is in accordance with our results of a 6% borderline significant reduction in MR-proADM levels ( P = 0.057) with no correlation to changes in BMI.

also in 11,409 other papers

borderline significanceno p-value reported

Conclusion In an RCT, liraglutide treatment in women with PCOS reduced levels of the cardiovascular risk biomarkers MR-proANP with 25% and MR-proADM with 6% (borderline significance) compared with placebo.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.